Not FDA-approved

Immune & defense

Thymosin alpha-1

Evidence

Approved in some countries, not the U.S.

Class

28-amino-acid thymic peptide

/

Thymosin alpha-1

KEY TAKEAWAY

Thymosin alpha-1 is a peptide first isolated from the thymus gland. It is approved in some countries as an immune modulator for hepatitis and as a vaccine adjunct, but it is not approved by the FDA.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

A thymus-derived peptide that modulates immune activity

Studied for

Hepatitis B and C, vaccine response and severe infections

Key fact

Used as a drug in several countries; trial results are mixed

Route

Injection

Evidence strength

Approved in some countries, not the U.S.

What it is

What it is

Thymosin alpha-1, also called thymalfasin, is a synthetic version of a peptide produced in the thymus.

How it works

How it works

It appears to stimulate T cells and dendritic cells, helping the immune system respond to infection and vaccines.

Regulatory status

Regulatory status

Approved in several countries outside the U.S. under the name Zadaxin. It has no FDA approval.

What it is used for

What it is used for

Used in some countries for chronic hepatitis B and C and as an adjunct to vaccines in older or immunocompromised patients. Studied in sepsis with mixed results.

Side effects and risks

Side effects and risks

Injection-site reactions are the most commonly reported effect. Serious adverse events were uncommon in trials.

Citations

Citations

Primary literature for this entry is being compiled.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo